文献速递心血管泌尿生殖外周血管CTDSA

疑似冠心病患者静脉与动脉注射对比剂后肾损伤的随机试验

Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial.
PubMed 文献 · Radiology · 2019-07-02

前瞻性随机研究纳入320例疑似冠心病患者,比较静脉注射对比剂行冠状动脉CT血管成像与动脉注射行心导管造影后急性肾损伤的发生率;CT血管成像组急性肾损伤发生率5.6%低于导管组13.2%(相对风险2.4,95%CI 1.1-5.0,P=0.02),且急性肾损伤与慢性肾脏病相关(风险比12.4,95%CI 4.5-34.6,P<0.01)。

要点

  • 疑似冠心病患者中,心导管造影后急性肾损伤发生率高于CT血管成像(13.2% vs 5.6%)。
  • 无阻塞性冠心病且未行冠脉介入的亚组中,导管组急性肾损伤仍高于CT血管成像组(11.9% vs 4.3%)。
  • 造影后急性肾损伤与慢性肾脏病相关(风险比12.4,95%CI 4.5-34.6,P<0.01)。

核心结论

  • 在这项疑似冠心病患者的前瞻性随机研究中,心导管造影后急性肾损伤比CT血管成像后更常见。

研究设计与样本

  • 前瞻性随机研究(ClinicalTrials.gov注册号NCT00844220),2009年2月至2015年8月纳入320例非典型胸痛且疑似冠心病的参与者,随机分为静脉注射对比剂行冠状动脉CT血管成像组或动脉注射对比剂行心导管造影组。
  • 本预设次要分析由设盲研究者比较急性肾损伤(18-24小时或46-50小时血清肌酐升高≥25%或0.5 mg/dL),采用绝对差值和相对风险及双侧95%CI。
  • 共纳入320例参与者(女性163例[50.9%],平均年龄60岁±11),CT血管成像组基线eGFR 84.3 mL/min/1.73 m2±17.2,导管组87.1 mL/min/1.73 m2±16.7(P=0.14)。

诊断标准与关键数值

  • 急性肾损伤定义为18-24小时或46-50小时血清肌酐较基线升高≥25%或0.5 mg/dL。
  • CT血管成像组急性肾损伤9/161例(5.6%,95%CI 3%-10%),导管组21/159例(13.2%,95%CI 9%-19%),相对风险2.4(95%CI 1.1-5.0,P=0.02)。
  • 无阻塞性冠心病且未行冠脉介入亚组中,导管组急性肾损伤11.9%(95%CI 8%-19%)高于CT血管成像组4.3%(95%CI 2%-9%),差值7.7%(95%CI 1.3%-14.1%),相对风险2.8(95%CI 1.1-7.0,P=0.02)。
  • 阻塞性冠心病(比值比2.7,95%CI 1.1-6.6,P=0.02)、股动脉穿刺入路(比值比2.5,95%CI 1.1-5.6,P=0.04)和电影心室造影(比值比2.3,95%CI 1.0-4.9,P=0.03)与急性肾损伤相关。
  • 多变量分析中,造影后急性肾损伤与慢性肾脏病相关(风险比12.4,95%CI 4.5-34.6,P<0.01)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background In the absence of randomized studies, it has been controversial whether the likelihood of acute kidney injury (AKI) differs between intravenous and intra-arterial contrast agent administration. Purpose To compare intravenous versus intra-arterial contrast agent administration in relationship to AKI and analyze the association between AKI and chronic kidney disease (defined as at least mildly decreased estimated glomerular filtration rates [eGFRs]). Materials and Methods This was a prospective study (ClinicalTrials.gov: NCT00844220) that involved randomizing participants with atypical chest pain and suspected coronary artery disease (CAD) between February 2009 and August 2015 to undergo coronary CT angiography with intravenous contrast agent administration or cardiac catheterization angiography with intra-arterial contrast agent administration. This prespecified secondary analysis compared AKI (serum creatinine increase of ≥ 25% or 0.5 mg/dL after 18-24 or 46-50 hours) determined by blinded investigators using absolute differences and relative risks, including two-sided 95% confidence intervals (CIs). Results A total of 320 participants (163 [50.9%] women; mean age, 60 years ± 11) were included. Baseline eGFR did not differ between the CT angiography group (84.3 mL/min/1.73 m2 ± 17.2) and the catheterization group (87.1 mL/min/1.73 m2 ± 16.7) (P = .14). AKI occurred in nine of 161 participants in the CT angiography group (5.6%; 95% CI: 3%, 10%) and in 21 of 159 participants in the catheterization group (13.2%; 95% CI: 9%,19%) (relative risk, 2.4; 95% CI: 1.1, 5.0; P = .02). Also in the subgroup of participants without obstructive CAD, in those not requiring coronary interventions, AKI was more common in the catheterization group (11.9%; 95% CI: 8%, 19%) than in the CT angiography group (4.3% [95% CI: 2%, 9%]; difference, 7.7% [95% CI: 1.3%, 14.1%]; relative risk, 2.8 [95% CI: 1.1, 7.0]; P = .02). Obstructive CAD (odds ratio [OR]: 2.7 [95% CI: 1.1, 6.6]; P = .02), femoral catheter access (OR: 2.5 [95% CI: 1.1, 5.6]; P = .04), and cine ventriculography were associated with AKI (OR: 2.3 [95% CI: 1.0, 4.9]; P = .03). In multivariable analysis, the presence of postcontrast AKI was associated with chronic kidney disease (hazard ratio: 12.4 [95% CI: 4.5, 34.6]; P < .01). Conclusion Acute kidney injury was more common after cardiac catheterization than after CT angiography in this prospective randomized study of patients suspected of having coronary artery disease. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Einstein and Newhouse in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Schönenberger E, Martus P, Bosserdt M, et al. Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial. Radiology. 2019. PMID: 31264950. doi:10.1148/radiol.2019182220

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。